News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Panbela Therapeutics Inc
(NQ:
PBLA
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Mar 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
1.020 (5)
Ask (Size)
1.040 (1)
Prev. Close
1.110
Today's Range
N/A - N/A
52wk Range
1.060 - 46.00
Shares Outstanding
5,127,686
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
PBLA Stock Earnings: Panbela Therapeutics Misses EPS for Q1 2024
May 15, 2024
PBLA stock results show that Panbela Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac
May 06, 2024
Developed in collaboration with Sanofi.
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
Performance
More News
Read More
Panbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024
May 01, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
Recap: Panbela Therapeutics Q4 Earnings
March 26, 2024
Via
Benzinga
Earnings Preview: Panbela Therapeutics
March 25, 2024
Via
Benzinga
Acceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Digestive Disease Week
April 30, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025
April 22, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
Panbela Announces Poster Presentation at American Association for Cancer Research:
April 18, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
Panbela Announces Transfer to OTCQB Market
April 16, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
PBLA Stock Earnings: Panbela Therapeutics Misses EPS for Q4 2023
March 26, 2024
Via
InvestorPlace
Panbela to Host Fourth Quarter and Year End 2023 Earnings Conference Call on March 26, 2024
March 12, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
Top 4 Health Care Stocks That Are Preparing To Pump This Month
February 23, 2024
Via
Benzinga
Panbela Regains Compliance with Nasdaq Listing Standards for Bid Price and Publicly Held Shares Requirements
February 15, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 14, 2024
Via
Benzinga
BioMedNewsBreaks – Panbela Therapeutics Inc. (NASDAQ: PBLA) Secures ~$9M in Public Offering
February 01, 2024
Via
Investor Brand Network
Panbela Announces Closing of Approximately $9.0 Million Public Offering
February 01, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
What's Going On With Panbela Therapeutics Stock Today?
January 30, 2024
Via
Benzinga
Acceptance of Ivospemin (SBP-101) Abstract for Poster Presentation at American Association for Cancer Research (AACR)
January 30, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
Crude Oil Down Over 1%; Science 37 Holdings Shares Spike Higher
January 29, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 29, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 29, 2024
Via
Benzinga
Dow Edges Lower; Cardlytics Shares Jump
January 29, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
US Stocks Edge Higher; Amazon And iRobot Agree To Terminate Acquisition Deal
January 29, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Aclarion (ACON) Stock Down 16% Today?
January 29, 2024
Via
InvestorPlace
Why Is Panbela Therapeutics (PBLA) Stock Down 63% Today?
January 29, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.